Codiak Biosciences’ Exosome Therapeutics Attracts Jazz Pharmaceuticals
By Michelle Liu
Pharma Deals Review: Vol 2019 Issue 1 (Table of Contents)
Published: 30 Jan-2019
DOI: 10.3833/pdr.v2019.i1.2400 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
Investing in its cancer and haematological portfolio, Jazz Pharmaceuticals has partnered up with Codiak Biosciences to develop exosome therapeutics in a deal worth US$1...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS